Found: 65
Select item for more details and to access through your institution.
Metastatic Colorectal Cancer 2.0.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2562, doi. 10.3390/jcm13092562
- By:
- Publication type:
- Article
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231212184
- By:
- Publication type:
- Article
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5451, doi. 10.3390/cancers15225451
- By:
- Publication type:
- Article
Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5189, doi. 10.3390/cancers15215189
- By:
- Publication type:
- Article
Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 14283, doi. 10.3390/ijms241814283
- By:
- Publication type:
- Article
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer.
- Published in:
- Nutrients, 2023, v. 15, n. 16, p. 3604, doi. 10.3390/nu15163604
- By:
- Publication type:
- Article
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40220-7
- By:
- Publication type:
- Article
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 7, p. 1391, doi. 10.1038/s41416-023-02180-7
- By:
- Publication type:
- Article
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1147849
- By:
- Publication type:
- Article
Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1056002
- By:
- Publication type:
- Article
Neoadjuvant therapy in pancreatic ductal adenocarcinoma: A competing risk analysis.
- Published in:
- Surgical Practice, 2022, v. 26, n. 3, p. 155, doi. 10.1111/1744-1633.12578
- By:
- Publication type:
- Article
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.745701
- By:
- Publication type:
- Article
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 8, p. 1200, doi. 10.3390/biom11081200
- By:
- Publication type:
- Article
Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination with 5‐Fluorouracil in the FOLFIRI Regimen.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1314, doi. 10.1002/onco.13762
- By:
- Publication type:
- Article
Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 780, doi. 10.3390/biom11060780
- By:
- Publication type:
- Article
Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284821989559
- By:
- Publication type:
- Article
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284821989559
- By:
- Publication type:
- Article
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920977139
- By:
- Publication type:
- Article
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920958363
- By:
- Publication type:
- Article
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920937427
- By:
- Publication type:
- Article
Molecular and Translational Research on Colorectal Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3532, doi. 10.3390/ijms21103532
- By:
- Publication type:
- Article
Prognostic Role of a New Inflammatory Index with Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase (CII: Colon Inflammatory Index) in Patients with Metastatic Colorectal Cancer: Results from the Randomized Italian Trial in Advanced Colorectal Cancer (ITACa) Study [Corrigendum]
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 541, doi. 10.2147/CMAR.S242995
- By:
- Publication type:
- Article
Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Special Issue on Basic and Translational Research in Colorectal Cancer.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4357, doi. 10.2147/CMAR.S198651
- By:
- Publication type:
- Article
Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 663, doi. 10.3390/cancers11050663
- By:
- Publication type:
- Article
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study.
- Published in:
- World Journal of Surgical Oncology, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12957-019-1602-z
- By:
- Publication type:
- Article
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 12, p. 3733, doi. 10.3390/ijms19123733
- By:
- Publication type:
- Article
IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 5659, doi. 10.2147/CMAR.S181570
- By:
- Publication type:
- Article
Radiofrequency Ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 6555, doi. 10.2147/OTT.S170836
- By:
- Publication type:
- Article
Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 5261, doi. 10.2147/OTT.S166614
- By:
- Publication type:
- Article
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results.
- Published in:
- Oncologist, 2017, v. 22, n. 8, p. 886, doi. 10.1634/theoncologist.2017-0206
- By:
- Publication type:
- Article
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 6, p. 1240, doi. 10.3390/ijms18061240
- By:
- Publication type:
- Article
Immune Checkpoints as a Target for Colorectal Cancer Treatment.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 6, p. 1324, doi. 10.3390/ijms18061324
- By:
- Publication type:
- Article
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article